HOVERINK

hoverink-logo

Hoverink is a biopharmaceutical company that aims to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments. The company's products include bullet-resistant clothing, bullet-resistant vests, bullet-proof vests, hard plate personal body armor, protective body armor, stab-resistant vests and drug for the treatment of chronic pain, nausea and discomfort, enabling American soldiers to protect themselves from incoming fire and patients to get sound treatment for age-related diseases, cancer, infectious diseases, among others.

#SimilarOrganizations #People #Website #More

HOVERINK

Social Links:

Industry:
Biopharma Biotechnology Consumer Electronics Hardware Medical Pharmaceutical

Founded:
2012-01-31

Address:
Los Angeles, California, United States

Country:
United States

Website Url:
http://www.hoverinkbiotech.yolasite.com

Total Employee:
1+

Status:
Active

Contact:
(888)511-7358

Email Addresses:
[email protected]

Total Funding:
220 K USD

Technology used in webpage:
Domain Not Resolving


Similar Organizations

fedora-pharmaceuticals-logo

Fedora Pharmaceuticals

Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.


Current Advisors List

davidra-sajna_image

Davidra Sajna Chairman @ Hoverink
Board_member
2012-02-06

Current Employees Featured

cyrus-sajna_image

Cyrus Sajna
Cyrus Sajna Founder, Director & Interim CEO/CFO @ Hoverink
Founder, Director & Interim CEO/CFO
2012-01-01

Founder


cyrus-sajna_image

Cyrus Sajna

davidra-sajna_image

Davidra Sajna

mike-adams_image

Mike Adams

Official Site Inspections

http://www.hoverinkbiotech.yolasite.com

  • Host name: 172.64.144.105
  • IP address: 172.64.144.105
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Hoverink"

Hoverink - Crunchbase Company Profile & Funding

Hoverink is a biopharmaceutical company that aims to improve the lives of patients who suffer from rare diseases for which there are limited or no available treatments.See details»

Hoverink Biotechnologies, Inc.: Drug pipelines, Patents, Clinical ...

Jul 9, 2023 Explore Hoverink Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

Hoverink Biotechnologies, Inc. - Wiki | Golden

Hoverink Biotechnologies, Inc. is a Los Angeles-based company. Overview Structured Data Issues Contributors Activity. ContentsSee details»

Hoverink Biotechnologies Inc - Company Profile and News

Company profile page for Hoverink Biotechnologies Inc including stock price, company news, executives, board members, and contact informationSee details»

Hoverink Biotechnologies, Inc., today announced โ€ฆ

Los Angeles, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be โ€ฆSee details»

Hoverink Biotechnologies - PitchBook

Hoverink Biotechnologies General Information Description. Manufacturer of transparent body armor, clothing, and therapeutic product created to protect American soldiers and local law โ€ฆSee details»

Hoverink Biotechnologies, Inc., today announced Hoverink CEO โ€ฆ

/EIN News/ -- Los Angeles, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be succeeded by Cyrus โ€ฆSee details»

Hoverink Biotechnologies, Inc.:Company Profile & Technical โ€ฆ

Discovery Company profile page for Hoverink Biotechnologies, Inc. including technical research,competitor monitor,market trends,company profile& stock symbolSee details»

Hoverink - Products, Competitors, Financials, Employees, โ€ฆ

Why We Started This Company Will the World have HoverBoards By 2015. Use the CB Insights Platform to explore Hoverink's full profile.See details»

Hoverink Biotechnologies, Inc., today announced that they

Nov 9, 2018 Overview On September 26, 2018 We filed trademark applications covering: LOS ANGELES, CA, Nov. 09, 2018 (GLOBE NEWSWIRE) --...See details»

Hoverink Biotechnologies, Inc., today announced that they have ...

See details»

LADAVRU® NEWS โ€œHOVERINK BIOTECHNOLOGIES SEEKS โ€ฆ

Jul 5, 2018 ladavru® news โ€œhoverink biotechnologies seeks commercial partnering opportunities in oncology supportive therapies and seeks a commercialization agreement for its โ€ฆSee details»

HOVERINK BIOTECHNOLOGIES INITIATES PRIVATE PLACEMENT โ€ฆ

Apr 28, 2018 LOS ANGELES, CA, April 27, 2018 -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and other conditions, $2.5 million of Series A โ€ฆSee details»

LADAVRU® NEWS โ€œHOVERINK BIOTECHNOLOGIES SEEKS โ€ฆ

LOS ANGELES, CA, July 05, 2018 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES, seeks to enter into a licensing agreement for the exclusive rights to commercialize โ€ฆSee details»

Hoverink Biotechnologies, Inc., today announced that they have ...

Nov 12, 2018 Overview LOS ANGELES, CA, Nov. 12, 2018 -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word Mark MAXKAFLEN Goods and โ€ฆSee details»

HOVERINK BIOTECHNOLOGIES INITIATES PRIVATE PLACEMENT โ€ฆ

Apr 28, 2018 Contact Data Contact: Cyrus Sajna Vice-President Hoverink Biotechnologies Inc, 1801 CENTURY PARK EAST, 24TH FLOOR LOS ANGELES, CA 90067 [email protected] โ€ฆSee details»

HOVERINK BIOTECHNOLOGIES INITIATES PRIVATE PLACEMENT โ€ฆ

LOS ANGELES, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and oth...See details»

Hoverink Biotechnologies, Inc., today announced Hoverink CEO

Jan 23, 2020 Hoverink Biotechnologies announced today that CEO Debbie Mae Carter will step down and will be succeeded by Cyrus Sajna as CEO and CFO of the company.See details»

Hoverink Biotechnologies, Inc., today announced that they

Nov 12, 2018 Overview LOS ANGELES, CA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- On September 26, 2018 We filed trademark applications covering: MAXKAFLEN® Word...See details»

BODY GLOBE BODY ARMOR® COMPLETES LEVEL II BALLISTICS โ€ฆ

LOS ANGELES, CA, April 02, 2019 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today that on February 28, 2019, HP White concluded its level II ballistics test for โ€ฆSee details»

linkstock.net © 2022. All rights reserved